Letter

Cancer of the upper gastrointestinal tract

BMJ 1994; 308 doi: 10.1136/bmj.308.6945.1716b (Published 25 June 1994)
Cite this as: BMJ 1994;308:1716.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. R J Donnelly,
  2. D J Girling,
  3. P M Fayers
  1. Cardiothoracic Centre, Liverpool L14 3PE MRC
  2. Cancer Trials Office, 5 Shaftesbury Road, Cambridge CB2 2BW.

    EDITOR, - In their letter J G Weil and S J Munday provide further evidence of surgeons' experience as a prognostic factor and in their subsequent editorial S O'Reilly and A Forastiere draw attention to the potential value of multimodality in the management of oesophageal cancer. We wish to emphasise the worldwide paucity of randomised trials in this disease; this could well be delaying improvements in treatment. To help rectify this situation, in 1990 the Medical Research Council's Cancer Therapy Committee set up a working party to conduct a programme of multicentre randomised trials on treatment. This …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular